Replikun Biotech To Commercialise A West Nile Virus Vaccine Technology

May 26th, 2008 by admin

Australian immunogen and immunotherapy company, Replikun Biotech Pty Limited (Replikun) declared that they hit complete an inner authorise commendation with UniQuest Pty. Ltd. (UniQuest) to change a newborn West river virus immunogen technology. UniQuest is the important investigate development consort for The University of Queensland. The immunogen candidates licensed low this commendation were matured by Associate Professor Alex Khromykh and Dr.

Tags: ,

Posted in Immunology |

Related posts

Comments are closed.